ICA-121431

CAS No. 313254-51-2

ICA-121431( 22-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl )

Catalog No. M20736 CAS No. 313254-51-2

ICA-121431 is a nanomolar potent small molecule Nav1.7 channel inhibitor with IC50 of 19 nM for rat Nav1.7 with little or no activity against human Nav1.5 or Nav1.7 channels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 65 In Stock
2MG 38 In Stock
5MG 61 In Stock
10MG 86 In Stock
25MG 150 In Stock
50MG 246 In Stock
100MG 370 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ICA-121431
  • Note
    Research use only, not for human use.
  • Brief Description
    ICA-121431 is a nanomolar potent small molecule Nav1.7 channel inhibitor with IC50 of 19 nM for rat Nav1.7 with little or no activity against human Nav1.5 or Nav1.7 channels.
  • Description
    ICA-121431 is a nanomolar potent small molecule Nav1.7 channel inhibitor with IC50 of 19 nM for rat Nav1.7 with little or no activity against human Nav1.5 or Nav1.7 channels.
  • In Vitro
    ICA-121431 interacts with human Nav1.3 and the amino acid residues that may define selectivity for this channel over other related Nav?channels, including Nav1.7 and Nav 1.5. Data generated using conventional patch clamp electrophysiological recording using a pulse protocol whereby a 20-ms test pulse is preceded by an 8-s step to a voltage that inactivated half of the channels.ICA-121431 is against Wild type hNav1.3 hNav1.5 hNav1.7 with IC50s of 0.013 μM, >30 μM, 12 μM, respectively.ICA-121431 is againsthNav channels with point mutations,shows hNav1.3 M1 (S1510Y), hNav1.3 M2 (R1511W), hNav1.3 M3 (E1559D), hNav1.3 M1,3 (S1510Y/E1559D), hNav1.3 M2, 3 (R1511W/E1559D), hNav1.3 M1, 2, 3 (S1510Y/R1511W/E1559D), and hNav1.7 M1, 2, 3 (Y1537S/W1538R/D1586E) with IC50 values of 0.1 μM, 0.37 μM, 1.1 μM, 1.3 μM, 1.9 μM, 11.6 μM, 0.032 μM, respectively.ICA-121431 is againsthNav channels with point mutations,shows hNav1.3/hNav1.5 S1-S4, hNav1.3/hNav1.5 S3-S4, hNav1.3/hNav1.5 S5-S6, hNav1.3/hNav1.7 S1, hNav1.3/hNav1.7 S2, hNav1.3/hNav1.7 S3-S4, and hNav1.3/hNav1.7 S5-S6 with IC50 values of 0.083 μM, 1.2 μM, 11 μM, 2.0 μM, 0.045 μM, 0.030 μM, 0.30 μM, 1.0 μM, and 0.024 μM, respectively.
  • In Vivo
    ——
  • Synonyms
    22-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Nav1.7 channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    313254-51-2
  • Formula Weight
    449.55
  • Molecular Formula
    C23H19N3O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:44 mg/mL (97.88 mM)
  • SMILES
    O=C(Nc1ccc(cc1)S(=O)(=O)Nc1nccs1)C(c1ccccc1)c1ccccc1
  • Chemical Name
    22-diphenyl-N-(4-(N-(thiazol-2-yl)sulfamoyl)phenyl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Song G Yang D Wang Y et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators[J]. Nature 2017.
molnova catalog
related products
  • Trapencaine

    Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.

  • PF-06869206

    PF-06869206 is an oral selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1, IC50: 380 nM).

  • PF-05089771

    PF-05089771 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 11 nM.